London/Manila — Britain gave AstraZeneca’s Covid-19 vaccine a vote of confidence on Friday when it asked its regulator to assess the shot for a rollout. That was after experts raised questions about trial data and the company said it may run another study to gauge efficacy.

The UK government has secured 100-million doses of the vaccine, developed by AstraZeneca and Oxford University, the most it has ordered of any shot to fight a pandemic that has killed more than 1.4-million people globally...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now